Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients. (Q35704971)
Jump to navigation
Jump to search
scientific article published on August 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients. |
scientific article published on August 2015 |
Statements
Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients (English)
Patricia Pérez-Matute
Laura Pérez-Martínez
Javier Aguilera-Lizarraga
1 August 2015